FDA’s legislative wish list includes device cybersecurity, a generic exclusivity fix, and more
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesBiotechnologyMedical DevicesNorth AmericaPharmaceuticalsProduct LifecycleRegulatory NewsFerdous Al-FaruqueBiologics/ biosimilars/ vaccinesBiotechnologyMedical DevicesNorth AmericaPharmaceuticalsProduct Lifecycle